Page last updated: 2024-11-07

oxandrolone and Wasting Disease

oxandrolone has been researched along with Wasting Disease in 4 studies

Oxandrolone: A synthetic hormone with anabolic and androgenic properties.

Research Excerpts

ExcerptRelevanceReference
" Oxandrolone is reported to be generally well tolerated and the most commonly documented adverse effects are transient elevations in transaminase levels and reductions in high density lipoprotein cholesterol level."2.42The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. ( Fiatarone Singh, M; Orr, R, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gullett, NP1
Hebbar, G1
Ziegler, TR1
Orr, R1
Fiatarone Singh, M1
Akyurek, M1
Dunn, RM1
Mann, M1

Reviews

3 reviews available for oxandrolone and Wasting Disease

ArticleYear
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.
    The American journal of clinical nutrition, 2010, Volume: 91, Issue:4

    Topics: Anabolic Agents; Cachexia; Clinical Trials as Topic; Ghrelin; Human Growth Hormone; Humans; Megestro

2010
The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.
    Drugs, 2004, Volume: 64, Issue:7

    Topics: Aging; Anabolic Agents; Androgens; Humans; Oxandrolone; Randomized Controlled Trials as Topic; Wasti

2004
Oxandrolone.
    Plastic and reconstructive surgery, 2006, Volume: 118, Issue:3

    Topics: Adult; Anabolic Agents; Appetite; Child; Female; Humans; Male; Oxandrolone; Randomized Controlled Tr

2006

Other Studies

1 other study available for oxandrolone and Wasting Disease

ArticleYear
Approved pharmacologic interventions for wasting: an overview and lessons learned.
    The Journal of nutrition, 1999, Volume: 129, Issue:1S Suppl

    Topics: Anabolic Agents; Appetite Stimulants; Clinical Trials as Topic; Dronabinol; Human Growth Hormone; Hu

1999